Technical Analysis for SBM - Sirona Biochem Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 200 DMA | Bearish | -7.14% | |
| Fell Below 50 DMA | Bearish | -7.14% | |
| 20 DMA Support | Bullish | -7.14% | |
| Golden Cross | Bullish | -7.14% | |
| MACD Bullish Centerline Cross | Bullish | -7.14% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| 2x Volume Pace | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
| Down 1 ATR | 5 days ago |
| Fell Below Previous Day's Low | 5 days ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-09-27
Sirona Biochem Corp. Description
Sirona Biochem Corp. is a Canada-based development-stage cosmetic ingredient and drug discovery company with a technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. It is engaged in the development of cosmetic and pharmaceutical active ingredients, which are licensed to its partners. The Company has six product lines: SGLT2 Inhibitor, Skin Lightener I, GlycoProteMin-Anti aging, Anti-inflammatory, Anti-infective and Skin Lightener II. Its development is focused on three programs: therapeutics, which includes diabetes, anti-inflammatories and anti-infectives; cosmeceuticals, which includes anti-aging and depigmenting agents (skin lighteners), and biological ingredients, which includes inducers and adjuvants for biological development and preservation. The Company, through TFChem S.A.R.L. (TFC), is engaged in using fluorine atom properties to develop glycomimetic compounds.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharma Light Pharmaceutical Labor Drug Skin Health Sciences Pharmaceutical Industry Diabetes Biological Anti Infectives Cosmetics Drug Discovery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.12 |
| 52 Week Low | 0.02 |
| Average Volume | 94,118 |
| 200-Day Moving Average | 0.071 |
| 50-Day Moving Average | 0.071 |
| 20-Day Moving Average | 0.067 |
| 10-Day Moving Average | 0.068 |
| Average True Range | 0.007 |
| RSI (14) | 46.24 |
| ADX | 16.96 |
| +DI | 26.551 |
| -DI | 31.333 |
| Chandelier Exit (Long, 3 ATRs) | 0.058 |
| Chandelier Exit (Short, 3 ATRs) | 0.072 |
| Upper Bollinger Bands | 0.079 |
| Lower Bollinger Band | 0.055 |
| Percent B (%b) | 0.42 |
| BandWidth | 37.015 |
| MACD Line | 0.000 |
| MACD Signal Line | -0.001 |
| MACD Histogram | 0.0003 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.065 | ||||
| Resistance 3 (R3) | 0.065 | 0.065 | 0.065 | ||
| Resistance 2 (R2) | 0.065 | 0.065 | 0.065 | 0.065 | |
| Resistance 1 (R1) | 0.065 | 0.065 | 0.065 | 0.065 | 0.065 |
| Pivot Point | 0.065 | 0.065 | 0.065 | 0.065 | 0.065 |
| Support 1 (S1) | 0.065 | 0.065 | 0.065 | 0.065 | 0.065 |
| Support 2 (S2) | 0.065 | 0.065 | 0.065 | 0.065 | |
| Support 3 (S3) | 0.065 | 0.065 | 0.065 | ||
| Support 4 (S4) | 0.065 |
